Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development

by Eszter Ostorhazi, Ralf Hoffmann, Nicole Herth, John D. Wade, John D. Wade, Carl N. Kraus, Laszlo Otvos Jr., Laszlo Otvos Jr., Laszlo Otvos Jr.
Published 2018-08-01

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo

by Laszlo Otvos Jr., Laszlo Otvos Jr., Laszlo Otvos Jr., Eszter Ostorhazi, Dora Szabo, Steven D. Zumbrun, Lynda L. Miller, Stephanie A. Halasohoris, Puvi D. Desai, Sharon M. Int Veldt, Carl N. Kraus
Published 2018-08-01